|Articles|March 9, 2022
UBC Acquires MarketShare Movers
Acquisition will extend UBC's services to include an affordability solution.
Advertisement
UBC announced that it has acquired MarketShare Movers ("MSM"), a data-driven prescription drug benefit and affordability company. With this acquisition, UBC is extending its services to include an innovative affordability solution to patients and clients.
Read more about the acquistion
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
2
What Impact will DTC Programs have on Generic Drug Prices?
3
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
4
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
5
